Skip to content

Effect of bromelain and curcumin supplement in osteoarthritis

Evaluation of bromelain and curcumin supplement in osteoarthritis outpatients, Randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230629058615N4
Enrollment
55
Registered
2024-09-07
Start date
2024-10-22
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of bromelain and curcumin supplement in knee osteoarthritis. Osteoarthritis of knee, unspecified

Interventions

Intervention 1: Intervention group 1: The first group, consisting of 20 patients, will receive 200 mg of Celecoxib once daily for one month. Intervention 2: Intervention group 2:The second group, also

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients over 18 years old and suffer from non-infectious knee osteoarthritis

Exclusion criteria

Exclusion criteria: Sensitivity to pineapple ,celery, carrot and fennel Haemophilia Who take two antiplatelet drugs or one antiplatelet drug and one anticoagulant drug Suspicion of infection severe kidney impairment ( GFR< 30) severe liver impairment (child Pugh C and B ) Pregnant and breastfeeding women

Design outcomes

Primary

MeasureTime frame
Reduction of knee inflammation. Timepoint: The first week, the end of the second week, and the end of the month. Method of measurement: Measurement by WOMAC scale and Visual Analogue Scale.

Secondary

MeasureTime frame
Examination of the inflammatory process and pain level. Timepoint: Week one, end of week 2 , and end of the month. Method of measurement: Evaluation of factors in the knee functional questionnaire and visual analogue scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Rezazadeh

Iran University of Medical Sciences

pooyanorozi75@gmail.com+98 21 6044 8161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026